Skip to content

Study on intestinal microbiota, cognitive function and inflammation level of shift nurses

Study on intestinal microbiota, cognitive function and inflammation level of shift nurses

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065721
Enrollment
Unknown
Registered
2022-11-14
Start date
2022-11-14
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disturbance of sleep rhythm

Interventions

intervention group:Probiotic Supplements
control group:Placebo
non rotating nurse observation group:N/A

Sponsors

The First Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria of study group: (1) Have worked shifts for at least 12 weeks, one night shift every 4 days; (2) Type of Mediterranean diet; (3) No gender limit, aged 18-35 years; (4) Sign the informed consent; (5) No cognitive impairment as assessed by Montreal Cognitive Scale. 2. Inclusion criteria of control group: (1) Nurses who have not been on shift for at least 12 weeks; (2) Type of Mediterranean diet; (3) No gender limit, aged 18-35 years; (4) Sign the informed consent; (5) No cognitive impairment as assessed by Montreal Cognitive Scale.

Exclusion criteria

Exclusion criteria: 1. Suffer from mental disorders or epilepsy; 2. Patients with mental health problems who are receiving treatment or within six months prior to enrollment; 3. Patients with severe physical diseases or organic brain lesions; 4. Patients with gastrointestinal diseases such as Crohn's disease and ulcerative colitis; 5. Taking antibiotics or probiotic supplements in the current or 3 weeks prior to enrollment; 6. Patients planning pregnancy, pregnancy or lactation; 7. Undernourished or obese (BMI =30); 8. Patients with substance dependence such as drugs and alcohol; 9. Accompanied by severe sleep disorders, such as sleep apnea and restless legs; 10. Participating in other studies, which may affect the results of this study.

Design outcomes

Primary

MeasureTime frame
Gut microbiota abundance;

Countries

China

Contacts

Public ContactWang Yumei

The First Hospital of Hebei Medical University

Wangyumei19771021@hotmail.com+86 18633889983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026